Board Meetings for TORNTPHARM
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| TORNTPHARM | Torrent Pharmaceuticals Limited | 04 Feb 2016 | Results/Dividend | Inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited Review) on Consolidated Basis of the Company for the quarter and nine months ended on December 31, 2015. The Board would also consider payment of Interim Dividend for the year 2015-16. | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 29 Oct 2015 | Results | inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2015. | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 27 Jul 2015 | Results | Inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on June 30, 2015. | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 15 May 2015 | Results | inter alia, to consider the Audited Financial Results for the year ended on March 31, 2015. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 28 Jan 2015 | Results/Dividend | The Company had Informed Exchange that the meeting of the Board of Directors of the Company to be held on January 28, 2015 for, inter alia, considering and approving the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on December 31, 2014. The Company has now informed Exchange that the Board would also consider payment of lnterim Dividend for the year 2014-15. | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 28 Jan 2015 | Results | inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on December 31, 2014. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 05 Nov 2014 | Results | Inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2014. Further, as per the provisions of the Insider Trading Code of the Company, the trading window will remain closed between October 01, 2014 to November 06, 2014 (Board meeting for, inter alia, considering above results being held on November 05, 2014). | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 30 Jul 2014 | Results | Inter-alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for quarter ended June 30, 2014. Further the Company has informed that as per the provisions of the Insider Trading Code of the Company, the trading window will remain closed between July 01, 2014 to July 31, 2014 (Board meeting for, inter-alia, considering above results being held on July 30, 2014). | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 09 May 2014 | Results/Dividend | The Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on May 09, 2014 To consider ,inter alia, the Audited Financial Results for the year ended on March 31, 2014. Further as per the provisions of the Insider Trading Code of the Company, the trading window will remian closed between April 01, 2014 to May 10, 2014."The company has provided details of trading window period as per Prohibition of Insider Trading Regulations, 1992 issued by SEBI wherein when the trading window is closed, the employees/directors shall not trade in the company s securities in such period".The Company has now informed the Exchange that in the above meeting the Board would recommend the Final Dividend for the year ended on March 31, 2014.(purpose revised) | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 09 May 2014 | Results | To consider ,inter alia, the Audited Financial Results for the year ended on March 31, 2014. Further as per the provisions of the Insider Trading Code of the Company, the trading window will remian closed between April 01, 2014 to May 10, 2014. "The company has provided details of trading window period as per Prohibition of Insider Trading Regulations, 1992 issued by SEBI wherein when the trading window is closed, the employees/directors shall not trade in the company s securities in such period". | |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 21 Jan 2014 | Results | inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on December 31, 2013. Further as per the provisions of the Insider Trading Code of the Company, the trading window will remain closed between January 01, 2014 to January 22, 2014. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 21 Jan 2014 | Results/Dividend | The Company had informed the Exchange regarding Board Meeting to be held on January 21, 2014 , inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on December 31, 2013.The company has now informed the Exchange that the Board would also consider payment of Interim Dividend for the year 2013-14. (purpose revised) | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 30 Oct 2013 | Results | Inter alia, to consider & approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2013. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 26 Jul 2013 | Results | Inter alia, to consider & approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the Quarter ended June 30, 2013. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 30 May 2013 | Results/Dividend | To consider, inter alia, the Audited Financial Results of the Company for the year ended on March 31, 2013 and recommendation of dividend for the said year. | - |